Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tonix Pharmaceuticals

40.65
+2.245.83%
Post-market: 40.10-0.5500-1.35%19:59 EDT
Volume:728.83K
Turnover:29.43M
Market Cap:297.75M
PE:-0.23
High:41.77
Open:38.11
Low:38.06
Close:38.41
Loading ...

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

THOMSON REUTERS
·
03 Feb

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

GlobeNewswire
·
03 Feb

BRIEF-Tonix Pharmaceuticals Expects Topline Data For Tnx-1300 In Q3 2025, TNX-1500 In Q1 2025

Reuters
·
08 Jan

Tonix Pharmaceuticals Holding Corp - Expects Topline Data for Tnx-1300 in Q3 2025, Tnx-1500 in Q1 2025

THOMSON REUTERS
·
08 Jan

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team With Appointment of Gary Ainsworth as Vice President of Market Access

THOMSON REUTERS
·
08 Jan

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access

GlobeNewswire
·
08 Jan

Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences

GlobeNewswire
·
07 Jan

Tonix Pharmaceuticals Says FDA Set Target Action Date for Potential Fibromyalgia Drug

MT Newswires Live
·
23 Dec 2024

Tonix Pharmaceuticals Announces Pdufa Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for Tnx-102 Sl for Fibromyalgia

THOMSON REUTERS
·
23 Dec 2024

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

GlobeNewswire
·
23 Dec 2024

BRIEF-Tonix Pharmaceuticals Holding Corp - Increases Maximum Aggregate Offering Price To $250 Million

Reuters
·
21 Dec 2024

Tonix Pharmaceuticals Holding Corp - Increases Maximum Aggregate Offering Price to $250 Million

THOMSON REUTERS
·
21 Dec 2024

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Benzinga
·
18 Dec 2024

Crude Oil Down Over 1%; US Industrial Production Declines In November

Benzinga
·
18 Dec 2024

Tonix Pharmaceuticals Shares Jump After FDA Accepts NDA for Fibromyalgia Drug

MT Newswires Live
·
17 Dec 2024

Tonix Pharmaceuticals Gets FDA Review of Fibromyalgia Drug

Dow Jones
·
17 Dec 2024

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (Nda) for Tnx-102 Sl for Fibromyalgia

THOMSON REUTERS
·
17 Dec 2024

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

GlobeNewswire
·
17 Dec 2024

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire
·
17 Dec 2024

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

ACCESSWIRE
·
09 Dec 2024